We critically evaluate clinical evidence across major liver diseases, including viral hepatitis, drug-induced liver injury, alcoholic liver disease, non-alcoholic fatty liver disease, and autoimmune hepatitis, while highlighting heterogeneity in study designs, geographical concentration of evidence, and the predominance of positive findings that may reflect publication bias
Both cardiovascular activity and resistance training provide benefits
Several studies have found that MK-677 causes significant increases in GH levels in test subjects [5, 6, 7, 8]
May 28, 2026: Lawsuits in New Jersey Continue to Advance In addition to the federal MDLs, many GLP-1 lawsuits involving drugs like Wegovy have also been filed in New Jersey, where Novo Nordisk's U.S
Non-alcoholic fatty liver disease and neurological defects
Circuit diversification in a biofilm regulatory network